[Therapeutic effect of antiaggregants in patients with neurocirculatory asthenia with the initial signs of cerebral ischemia].
Therapeutic effect of antiaggregation drugs in patients with vasoautomomic dystonia with initial signs of insufficient blood supply to the brain. In 43 patients with vasoautonomic dystonia and initial manifestations fo cerebral circulation insufficiency, the effects of aggregation-inhibiting drugs (dipyrodamol, metindol, stugeron, prodectin) on blood coagulation and rheology, platelet aggregation and general hemodynamics were studied. Antiaggregation drugs were shown to be the tools of choice which could be administered with due account of baseline hemostasis and the type of cerebral hemocirculation, and of their selective action on the carotid and vertebrobasilar cerebral vessels.
Lebedev
A A
AA
Burdakov
V V
VV
D000293:Adolescent; D000328:Adult; D001809:Blood Viscosity / Q000187:drug effects* / Q000502:physiology; D002545:Brain Ischemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002986:Clinical Trials as Topic; D006801:Humans; D008875:Middle Aged; D009449:Neurocirculatory Asthenia / Q000097:blood / Q000150:complications*; D010974:Platelet Aggregation / Q000187:drug effects* / Q000502:physiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D013997:Time Factors
D010975:Platelet Aggregation Inhibitors
Lechebnyĭ éffekt antiagregantov u bol'nykh vegetativnososudistoĭ distonieĭ s nachal'nymi proiavleniiami nedostatochnosti krovosnabzheniia mozga.